DHX36在乳腺癌的进展和侵袭性方面起着致癌作用
Chunli Wei1, Dongmei Xu1,2, Jingliang Cheng1
1Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, 319 Zhongshan Road, Luzhou, 646000, Sichuan Province, China.
DHX36是一种DNA/RNA螺旋酶,促进乳腺癌的生长和转移. 向DHX36可能会提供一种新的乳腺癌治疗策略,因为它作为一种潜在的生物标志物.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 乳腺癌治疗面临着当前向药物的局限性.
- DHX36 (DNA螺旋酶II) 是一种依赖ATP的螺旋酶,参与DNA和RNA中的氨酸四重复合体 (G4s) 的解.
- DHX36在乳腺癌进展中的作用及其作为治疗点的潜力在很大程度上仍未被探索.
研究的目的:
- 研究DHX36在乳腺癌细胞增殖,迁移和入侵中的作用.
- 为了确定临床乳腺瘤组织中DHX36的表达水平.
- 评估DHX36表达和患者预后之间的相关性.
主要方法:
- 在体外研究涉及乳腺癌细胞中DHX36的过度表达,淘汰和淘汰.
- 在体内实验以评估瘤生长和转移.
- 在临床乳腺瘤样本中分析DHX36表达和与无复发生存率 (RFS) 的相关性.
主要成果:
- 在体外,DHX36的过度表达增强了乳腺癌细胞的生长,迁移和侵入.
- 在体外和体内,DHX36的淘汰或淘汰抑制了这些过程.
- 与健康组织相比,DHX36在乳腺瘤中显著过度表达,与较差的RFS相关.
结论:
- DHX36作为原瘤基因,促进乳腺癌的生长和转移.
- DHX36是一种潜在的乳腺癌诊断和预后生物标志物.
- 准DHX36或与之相关的G4结构是一个有希望的新型抗癌策略.
更多相关视频
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
06:36A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
相关概念视频
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitogens and the Cell Cycle
Hedgehog Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Abnormal Proliferation
